Pharmacovigilance and Public Health Ethics-Reference-Cited by-同舟云学术

Pharmacovigilance and Public Health Ethics

Published:2013-04-20 Issue:3 Volume:27 Page:157-164
ISSN:1178-2595
Container-title:Pharmaceutical Medicine
language:en
Short-container-title:Pharm Med

Author:

Callréus Torbjörn

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s40290-013-0016-4.pdf

Reference52 articles.

1. Dawson A, Verweij M. Public Health Ethics: a manifesto. Public Health Ethics. 2008;1(1):1–2.

2. Buchanan DR, Miller FG. A public health perspective on research ethics. J Med Ethics. 2006;32(12):729–33.

3. World Health Organisation. The importance of pharmacovigilance: safety monitoring of medicinal products (online). http://apps.who.int/medicinedocs/pdf/s4893e/s4893e.pdf . Accessed 22 Aug 2012.

4. Waller P. Risk management planning: time to deliver. Pharmacoepidemiol Drug Saf. 2006;15(12):850–1.

5. Edwards IR. Prevention and pharmacovigilance: what should we do, what can we do? Drug Saf. 2012;35(2):87–90.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Randomised Controlled Trial at the Intersection of Research Ethics and Innovation;Pharmaceutical Medicine;2022-07-25

2. Deploying the Precautionary Principle to Protect Vulnerable Populations in Canadian Post-Market Drug Surveillance;Canadian Journal of Bioethics;2020-04-21

3. An Ethical Justification for Expanding the Notion of Effectiveness in Vaccine Post-Market Monitoring: Insights from the HPV Vaccine in Canada;Public Health Ethics;2015-01-29

4. Ethical considerations in post-market-approval monitoring and regulation of vaccines;Vaccine;2014-12